Giovedì 25 giugno 2026
09:00 – 16:40
- Ore 09:00 Meeting Presentation: Prof. Francesco Perri, Prof.ssa Morena Fasano, Prof. Francesco Longo
- Ore 09:10 Great of the Authorities – The importance of Site-Site Collaboration for Academic Research
Maurizio Di Mauro (Direttore Generale INT IRCCS Fondazione G. Pascale);
Prof. Fortunato Ciardiello (Direttore Oncologia Università Vanvitelli);
Prof. Alfredo Budillon (Direttore Scientifico INT IRCCS Fondazione G. Pascale)
Prof. Giordano Beretta (Presidio Ospedaliero di Pescara)
Prof. Franco Maria Buonaguro (INT IRCCS Foundation G Pascale, Naples)
SESSION I – EARLY DIAGNOSIS OF ORAL CAVITY CANCER: WHAT’S NEW?
Chairmen: Dr. Umberto Esposito, Dr. Salvatore Alfieri, Dr. Filippo Ricciardiello
- Ore 09:30 Diagnosis of OPDM: early symptoms and features – Dr.ssa Petra Claudia Camilla D’Orsi
- Ore 09:45 Management of OPDM: guidelines for optimal framing – Dr. Agostino Guida
- Ore 10:00 OPMD: pathological features – Dr. Gerardo Ferrara
- Ore 10:15 Alternative therapies for OPMD: the role of clinical Trials – Dr. Carlo Resteghini
- Ore 10:30 Discussion – Chairmen: Umberto Esposito, Dr. Salvatore Alfieri, Dr. Filippo Ricciardiello
SESSION II – EARLY DIAGNOSIS AND IMAGING SUPPORT IN SCCHN
Chairmen: Prof.ssa Maria Paola Belfiore, Dr. Raffaele Addeo
- Ore 11:00 Early diagnosis of Oral Cavity Lesion: the role of ultrasonography – Dr. Dario Di Stasio
- Ore 11:15 TC, MRI or integration? A crucial tool – Dr.ssa Irma Palescandolo
- Ore 11:30 Discussion – Chairmen: ssa Maria Paola Belfiore, Dr. Raffaele Addeo
SESSION III – LOCALLY ADVANCED SCCHN: UPDATES AND DASHED WHISHES
Chairmen: Prof. Claudio Caporale, Prof. Giovanni Dell’Aversana Orabona, Dr. Matteo Muto
- Ore 12:00 Surgical Management of advanced Oral Cavity Cancer: the role of reconstructive Surgery – Prof.ssa Chiara Copelli
- Ore 12:15 – Conservative Strategies in Locally Advanced SCCHN: what indications? – Dr.ssa Irene De Santo
- Ore 12:30 – The role of Induction Therapy in SCCHN: status of the art and future perspectives – Dr.ssa Loredana Palermo
- Ore 12:45 – Clinical Case and “response from the audience” – Dr. Pierre Guarino
SESSION IV – ROLE OF SUPPORTIVE THERAPY IN SCCHN MANAGEMENT
Chairmen: Prof. Giordano Beretta, Prof. Marco Cascella, Dr.ssa Valeria Turrà
- Ore 14:30 Malnutrition in patients with SCCHN: a very common feature – Dr.ssa Ileana Parascandolo
- Ore 14:45 Neoplastic cachexia: no way out - Dr. Vincenzo Zurlo
- Ore 15:00 Pain assessment in patients with SCCHN: what to do? – Dr.ssa Federica Monaco
- Ore 15:15 Antithrombotic prophylaxis in cancer patients: high risk in patients with SCCHN – Dr.ssa Matilde Pensabene
- Ore 15:30 Iron Supplementation and liver protection: supportive therapy or something more? - Dr.ssa Grazia Massaro
- Ore 15:45 Speech therapy and timing: a wall – Dr.ssa Marta Spampinato
- Ore 16:00 Importance of Drug-Drug Interaction assessment in the clinical practice – Dr.ssa MariaLuisa Marciano
- Ore 16:15 Clinical Case and “response from the audience” - Dr.ssa Arianna Piccirillo
- Ore 16:30 Discussion – Chairmen: Giordano Beretta Prof. Marco Cascella, Dr.ssa Valeria Turrà
Venerdì 26 giugno 2026
09:00 – 14:00
SESSION V – ADVANCED DISEASE AND MTD: THE KEYSTONE
Chairmen: Prof. Morena Fasano, Dr. Livio Blasi, Dr. Giuseppe Tortoriello
- Ore 09:00 The Role of Radiation Therapy in Recurrent/Metastatic Disease – ssa Francesca De Felice
- Ore 09:15 Systemic therapies and identification of the correct sequences – Dr.ssa Marianna Caterino
- Ore 09:30 Immunotherapy, Check-Point Inhibitors and…. CAR-T cells? – Dr.ssa Agata Laudani
- Ore 09:45 The Evolving Role of Electrochemotherapy in SCCHN – Prof. Francesco Longo
- Ore 10:00 Clinical Case and “response from the audience” – Dr.ssa Erica Perri
SESSION VI – FUTURE PERSPECTIVES AND TAKE HOME MESSAGE
- Ore 11:00 Promising Drugs in SCCHN: the role of bispecific antibodies – Prof. Paolo Bossi
- Ore 11:20 Open Clinical Trials in Italy and how to better perform – Prof. Francesco Perri
- Ore 11:40 Future options with subcutaneous ICI: the experience of Malignant Melanoma – ssa Margaret Ottaviano
- Ore 12:00 Discussion – Prof. Paolo Bossi and Prof. Franceco Perri
SESSION VII – TRANSLATIONAL INSIGHT IN SCCHN: A “RECENT” ERA
Chairmen: Prof. PieroSandro Tagliaferri, Prof. Francesco Sabbatino, Prof. Michele Caraglia
- Ore 12:30 HPV Related SCCHN: what is changed? - Dr.ssa Maria Lina Tornesello
- Ore 12:45 NPC and Nasopharyngeal Carcinoma: therapeutic implications – Dr. Alessio Cirillo
- Ore 13:00 Recurrent/Metastatic Thyroid carcinoma status of the art: the crucial support of Translational Research – Dr.ssa Daria Maria Filippini
- Ore 13:15 What have we learned from translational research in SCCHN? – Prof. Marco Carlo Merlano
- Ore 13:35 Discussion – Chairmen: PieroSandro Tagliaferri, Prof. Francesco Sabbatino, Prof. Michele Caraglia